Developing a therapeutic vaccine for getting rid of the integrated HBV-DNA from the genome gepatatsitov? And when it is about to be introduced into medical practice? I, the support of HBsAg, HBV-DNA in the blood is negative, a biopsy is not done, because the liver is not worried, but ALT levels ranged from 70 to 150 U / L, AST, GGT, bilirubin, thymol, AP is always the norm! I'm worried that the chronic carrier state could potentially serve as the development of hepatocellular carcinoma!

Respond Tatyana Stepanova, a gastroenterologist, hepatologist Yes, the vaccine is developed. Our center is planned to study on the effectiveness of the vaccine. Similar question: ... Mt. pancreatitis. Was always elevated bilirubin - more than 30, sometimes increased thymol. Last biochemistry ...